Related references
Note: Only part of the references are listed.Blood-Based Alzheimer's Biomarkers
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
Steffen Halbgebauer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen et al.
LANCET NEUROLOGY (2022)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
Joel Simren et al.
ALZHEIMERS & DEMENTIA (2021)
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease
Pratishtha Chatterjee et al.
TRANSLATIONAL PSYCHIATRY (2021)
Reactive astrocyte nomenclature, definitions, and future directions
Carole Escartin et al.
NATURE NEUROSCIENCE (2021)
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Claudiaf Cicognola et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study
Inge M. W. Verberk et al.
LANCET HEALTHY LONGEVITY (2021)
Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's
Fanny M. Elahi et al.
ALZHEIMERS & DEMENTIA (2020)
Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia
Cecilia Marelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Carolin Heller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage
Breton M. Asken et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
Alberto Benussi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Inge M. W. Verberk et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
An Overview of Astrocyte Responses in Genetically Induced Alzheimer's Disease Mouse Models
Fokion Spanos et al.
CELLS (2020)
Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase
Patrick Oeckl et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer's Disease
Celia G. Fernandez et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
An update on genetic frontotemporal dementia
Caroline Greaves et al.
JOURNAL OF NEUROLOGY (2019)
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment
Patrick Oeckl et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Progranulin: Functions and neurologic correlations
Ryan A. Townley et al.
NEUROLOGY (2018)
Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
C. J. Garwood et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease
Axel Petzold
BRAIN RESEARCH (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Seonmi Jo et al.
NATURE MEDICINE (2014)
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Willem Kamphuis et al.
NEUROBIOLOGY OF AGING (2014)
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
Ineke A. van Rossum et al.
NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Validation of the New Interpretive Guidelines for the Clinical Dementia Rating Scale Sum of Boxes Score in the National Alzheimer's Coordinating Center Database
Sid E. O’Bryant et al.
ARCHIVES OF NEUROLOGY (2010)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies
C Kersaitis et al.
ACTA NEUROPATHOLOGICA (2004)
Share Paper
